Targeting K-Ras directly.

被引：0
|
作者：
Shokat, Kevin [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA18
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [31] The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
    Parker, Jillian A.
    Mattos, Carla
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [32] Targeting β-Catenin in Hepatocellular Cancers Induced by Coexpression of Mutant β-Catenin and K-Ras in Mice
    Tao, Junyan
    Zhang, Rong
    Singh, Sucha
    Poddar, Minakshi
    Xu, Emily
    Oertel, Michael
    Chen, Xin
    Ganesh, Shanthi
    Abrams, Marc
    Monga, Satdarshan P.
    HEPATOLOGY, 2017, 65 (05) : 1581 - 1599
  • [33] K-ras oncogene mutation in pterygium
    Ozturk, B. T.
    Yildirim, M. S.
    Zamani, A.
    Bozkurt, B.
    EYE, 2017, 31 (03) : 491 - 498
  • [34] K-ras mutations in pancreatic cancer
    Grady, M
    Gaut, A
    Liu, JR
    Zhang, YP
    Zhang, H
    Weydert, C
    Domann, F
    Oberley, L
    Cullen, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S440 - S440
  • [35] Physiological analysis of oncogenic K-Ras
    Perez-Mancera, Pedro Antonio
    Tuveson, David A.
    REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 676 - +
  • [36] Targeting the GATA2 transcriptional network in K-Ras driven lung adenocarcinoma
    Kumar, Madhu S.
    Downward, Julian
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
  • [37] The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras
    Tsang, Wing Pui
    Kwok, Tim Tak
    CARCINOGENESIS, 2009, 30 (06) : 953 - 959
  • [38] K-ras as a target for cancer therapy
    Friday, BB
    Adjei, AA
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1756 (02): : 127 - 144
  • [39] Targeting K-ras mutant pancreatic cancer cells with vorinostat and 5-fluorouracil
    Chung, Vincent
    Gaur, Shikha
    Ann, David
    Yen, Yun
    CANCER RESEARCH, 2009, 69
  • [40] Targeting the α4–α5 dimerization interface of K-RAS inhibits tumor formation in vivo
    Imran Khan
    Russell Spencer-Smith
    John P. O’Bryan
    Oncogene, 2019, 38 : 2984 - 2993
12345